245 related articles for article (PubMed ID: 27118451)
1. Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells.
Smallwood DT; Apollonio B; Willimott S; Lezina L; Alharthi A; Ambrose AR; De Rossi G; Ramsay AG; Wagner SD
Blood; 2016 Jul; 128(4):542-52. PubMed ID: 27118451
[TBL] [Abstract][Full Text] [Related]
2. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
[TBL] [Abstract][Full Text] [Related]
3. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
5. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
Schuler M; Tretter T; Schneller F; Huber C; Peschel C
Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
[TBL] [Abstract][Full Text] [Related]
6. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
[TBL] [Abstract][Full Text] [Related]
7. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
9. Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.
Pasikowska M; Walsby E; Apollonio B; Cuthill K; Phillips E; Coulter E; Longhi MS; Ma Y; Yallop D; Barber LD; Patten P; Fegan C; Ramsay AG; Pepper C; Devereux S; Buggins AG
Blood; 2016 Jul; 128(4):563-73. PubMed ID: 27252234
[TBL] [Abstract][Full Text] [Related]
10. CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.
Girbl T; Hinterseer E; Grössinger EM; Asslaber D; Oberascher K; Weiss L; Hauser-Kronberger C; Neureiter D; Kerschbaum H; Naor D; Alon R; Greil R; Hartmann TN
Cancer Res; 2013 Jan; 73(2):561-70. PubMed ID: 23117883
[TBL] [Abstract][Full Text] [Related]
11. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
12. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
13. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
Krackhardt AM; Harig S; Witzens M; Broderick R; Barrett P; Gribben JG
Blood; 2002 Jul; 100(1):167-73. PubMed ID: 12070023
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?
Dubois K; Tannoury M; Bauvois B; Susin SA; Garnier D
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190234
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of T cell/B cell interaction by B-CLL cells.
Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
[TBL] [Abstract][Full Text] [Related]
16. CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis.
van Attekum MHA; van Bruggen JAC; Slinger E; Lebre MC; Reinen E; Kersting S; Eldering E; Kater AP
Haematologica; 2017 Dec; 102(12):2069-2076. PubMed ID: 28971904
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
Söderberg O; Christiansen I; Carlsson M; Nilsson K
Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
[TBL] [Abstract][Full Text] [Related]
19. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia.
Granziero L; Ghia P; Circosta P; Gottardi D; Strola G; Geuna M; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
Blood; 2001 May; 97(9):2777-83. PubMed ID: 11313271
[TBL] [Abstract][Full Text] [Related]
20. CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
Kater AP; Evers LM; Remmerswaal EB; Jaspers A; Oosterwijk MF; van Lier RA; van Oers MH; Eldering E
Br J Haematol; 2004 Nov; 127(4):404-15. PubMed ID: 15521917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
